|
761 |
Initial eGFR Changes with Ertugliflozin and Associations with Clinical Parameters: Analyses from the VERTIS CV Trial
Enthalten in American journal of nephrology Bd. 53, 2022, Nr. 7: 516-525. 10 S.
|
|
|
|
762 |
Extended-Release Calcifediol Effectively Raises Serum Total 25-Hydroxyvitamin D Even in Overweight Nondialysis Chronic Kidney Disease Patients with Secondary Hyperparathyroidism
Enthalten in American journal of nephrology Bd. 53, 2022, Nr. 6: 446-454. 9 S.
|
|
|
|
763 |
Integrated effects of ultrasonic scaling and subgingival irrigation with 0.12% chlorhexidine by a newly designed ultrasonic scaler tip in chronic periodontitis
Enthalten in Quintessence international Bd. 53, 2022, Nr. 4: 298-305
|
|
|
|
764 |
Phase-III-Studie beim Patienten mit metastasiertem kastrationsresistentem Prostatakarzinom (mCRPC)
Enthalten in Aktuelle Urologie Bd. 53, 2022, Nr. 03: 226-228
|
|
|
|
765 |
Kommentar zu „Muskelinvasives Urothelkarzinom: Nivolumab versus Placebo“
Enthalten in Aktuelle Urologie Bd. 53, 2022, Nr. 02: 112-114
|
|
|
|
766 |
Muskelinvasives Urothelkarzinom: Nivolumab versus Placebo
Enthalten in Aktuelle Urologie Bd. 53, 2022, Nr. 02: 110-112
|
|
|
|
767 |
Nicht fernmetastasiertes kastrationsresistentes Prostatakarzinom (M0CRPC)
Enthalten in Aktuelle Urologie Bd. 53, 2022, Nr. 01: 60-63
|
|
|
|
768 |
Aktuelle Entwicklungen in der Therapielandschaft des metastasierten hormonsensitiven Prostatakarzinoms (mHSPC)
Enthalten in Aktuelle Urologie Bd. 53, 2022, Nr. 01: 31-36
|
|
|
|
769 |
Clinical Utility of KidneyIntelX in Early Stages of Diabetic Kidney Disease in the CANVAS Trial
Enthalten in American journal of nephrology Bd. 53, 2022, Nr. 1: 21-31. 11 S.
|
|
|
|
770 |
Antithrombotische Therapie der oberflächlichen Venenthrombose
Enthalten in Phlebologie Bd. 51, 2022, Nr. 05: 245-250
|
|
Administration
